Guardian Pharmacy Services (NYSE:GRDN) Price Target Raised to $25.00

Guardian Pharmacy Services (NYSE:GRDN) had its target price upped by Truist Financial from $24.00 to $25.00 in a report issued on Friday morning,Benzinga reports. Truist Financial currently has a buy rating on the stock.

Guardian Pharmacy Services Stock Up 4.8 %

Shares of Guardian Pharmacy Services stock opened at $22.81 on Friday. The company has a fifty day moving average of $20.43 and a 200-day moving average of $20.64. Guardian Pharmacy Services has a 52-week low of $14.16 and a 52-week high of $25.74.

Institutional Inflows and Outflows

Several large investors have recently modified their holdings of the stock. R Squared Ltd bought a new position in Guardian Pharmacy Services during the 4th quarter worth approximately $30,000. Investment Research & Advisory Group Inc. bought a new position in shares of Guardian Pharmacy Services in the fourth quarter worth approximately $34,000. BNP Paribas Financial Markets purchased a new position in shares of Guardian Pharmacy Services in the fourth quarter worth $37,000. Compass Financial Services Inc bought a new stake in Guardian Pharmacy Services during the 4th quarter valued at $58,000. Finally, JPMorgan Chase & Co. purchased a new stake in Guardian Pharmacy Services during the 4th quarter valued at $77,000.

Guardian Pharmacy Services Company Profile

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes.